Diabetes Flashcards

1
Q

WHO diagnostic criteria for DM

A
1. Fasting plasma glucose:
 >= 126 mg/dl
2. Random blood glucose: 
 >= 200 mg/dl
3. 2 hr plasma glucose:
 >= 200 mg/dl by OGTT
4. HbA1c >= 6.5%

Diagnosis is made by performing these tests on separate occasions and days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pre-diabetes / Impaired Glucose tolerance

WHO diagnostic criteria

A
1. Fasting blood glucose:
 100-125 mg/dl
2. Random plasma glucose:
 140-199 mg/dl
3. HbA1c 5.7-6.4%

Diagnosis is made by performing these tests on separate occasions and days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Transient hyperglycemia

A

Acute states like infections, burns, trauma

Due to catecholamine release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HbA1c levels

A
Glucose + β globin
< 5.6 % normal
5.7 - 6.4 % prediabetic
>= 6.5 % diabetic
In a diabetic, maintain the HbA1c < 7%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Type 1 DM

basics

A

5-10 % of patients
Young adults
Due to autoimmune β cell destruction
2 factors: genetics, environmental

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Factors affecting DM type 1

A
Genetics factors:
• HLA on short arm of chr 6p
 HLA DR3, DR4, DQ8
• Polymorphism in CTLA4, PTPN22
Environmental:
 Virus - Coxsackie, mumps
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathogenesis of type 1 DM

A
  1. Autoantigens on β cells and circulate in blood stream and lymphatics
  2. Processing and presentation of autoantigen by antigen presenting cells
  3. Activation of TH1 & TH2
    • IFN-γ ➡️ macrophage activation with IL-1 and TNF-α release
    • IL-2 ➡️ activation of autoantigen specific cytotoxic T (CD8) cells
    • IL-4 ➡️ activation of B cells to produce islet cell autoantibodies and antiGAD65 antibodies
  4. Destruction of β cells with 🔽 insulin secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Factors affecting type 2 DM

A
No autoimmune etiology
Genetic:
• No HLA association
• polymorphism in TCFTL2 green
Environmental factors:
 Central/abdominal obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cardinal features of pathogenesis of type 2 DM

A
  1. 🔽 response of peripheral tissues

2. β cell dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Insulin resistance

mechanisms

A
  1. Failure to inhibit hepatic gluconeogenesis
  2. Failure of glucose uptake ➡️ glycogen synthesis in skeletal muscle
  3. Fat cells ➡️ failure to inhibit lipoprotein lipase ➡️ 🔼 circulation of free fatty acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why does obesity increase risk of insulin resistance

A
  1. Free fat acid production
  2. 🔼 in preglycemic adipokines like resistin & retinol binding protein
  3. Inflammation:
    🔼 cytokines ➡️ 🔽 insulin sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does free fatty acid 🔼 insulin resistance

& why is central obesity more harmful

A
  1. Central adipose tissue (more lipolytic than peripheral) ➡️
  2. Excess FFA ➡️ non-esterified FFA (NEFFA)
  3. Accumulation of toxic metabolites like DAG
  4. Attenuate signaling through insulin receptor pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Adipokines

A
1. Pre-glycemic:
 Resistin
 Retinol binding protein
2. Anti-glycemic:
 Leptin
 Adiponectin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Development of overt DM

A
  1. Insulin resistance ➡️ impaired glucose tolerance
  2. Initially β cell function 🔼 to compensate for insulin resistance
  3. Slowly β cells exhaust their capacity
  4. DM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DM complications

A
1. Acute:
 DKA
2. Chronic:
 Macrovascular: MI, PVD
 Microvascular:
  Retinopathy, neuropathy, nephropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pathogenesis of DM complications

A
  1. Formation of advanced glycation end products AGEs
  2. AGEs + RAGE receptors on inflammatory cell (macrophages)
  3. Activation of protein kinase-C
17
Q

Formation of advanced glycation end products AGEs

A

In DM
By non-enzymatic reaction between intracellular glucose intermediates like glyoxal + amino group of both intra & extra cellular proteins ➡️ AGEs

18
Q

AGEs + RAGE receptors on inflammatory cell (macrophages)

effects

A
  1. Release of cytokines like TGF-β, VEGF
  2. Generation of reactive oxygen species
  3. 🔼 procoagulant activity
  4. Enhanced proliferation of smooth muscle & 🔼 synthesis of extracellular matrix material